The T genotype of the MGMT C>T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patients von McDonald, K.L, Rapkins, R.W, Olivier, J, Zhao, L, Nozue, K, Lu, D, Tiwari, S, Kuroiwa-Trzmielina, J, Brewer, J, Wheeler, H.R, Hitchins, M.P

Volltext

Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry von Ward, Robyn L., Dobbins, Timothy, Lindor, Noralane M., Rapkins, Robert W., Hitchins, Megan P.

Volltext

Construction and evolution of imprinted loci in mammals von Hore, Timothy A, Rapkins, Robert W, Graves, Jennifer A. Marshall

Volltext

P08.22 Targeting glioblastoma mitochondrial metabolism to inhibit cell proliferation & tumor growth von Jue, T. J., Chung, S. A., Rapkins, R. W., Dilda, P., Hogg, P., McDonald, K. L.

Volltext

EG-11 DYSREGULATION OF MGMT IN GLIOBLASTOMA: FRIEND OR FOE? von Rapkins, R. W., Hitchins, M. P., McDonald, K. L.

Volltext

Characterizing the chromosomes of the Australian model marsupial Macropus eugenii (tammar wallaby) von Alsop, Amber E, Miethke, Pat, Rofe, Ruth, Koina, Edda, Sankovic, Natasha, Deakin, Janine E, Haines, Helen, Rapkins, Robert W, Marshall Graves, Jennifer A

Volltext

The role of TP53 gain-of-function mutation in multifocal glioblastoma von Olafson, Lauren R., Gunawardena, Manuri, Nixdorf, Sheri, McDonald, Kerrie L., Rapkins, Robert W.

Volltext

Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trial von Olafson, Lauren R., Siddell, Anna H., Field, Kathryn M., Byrnes, Madeleine, Rapkins, Robert W., Ng, Benedict, Nixdorf, Sheri, Barnes, Elizabeth H., Johns, Terrance G., Yip, Sonia, Simes, John, Nowak, Anna K., Rosenthal, Mark A., McDonald, Kerrie L.

Volltext

The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype von Kwok, Chau-To, Vogelaar, Ingrid P, van Zelst-Stams, Wendy A, Mensenkamp, Arjen R, Ligtenberg, Marjolijn J, Rapkins, Robert W, Ward, Robyn L, Chun, Nicolette, Ford, James M, Ladabaum, Uri, McKinnon, Wendy C, Greenblatt, Marc S, Hitchins, Megan P

Volltext

P11.21.A LONG-TERM SURVIVAL WITH IDH WILDTYPE GLIOBLASTOMA: FIRST RESULTS FROM THE ETERNITY BRAIN TUMOR FUNDERS’ COLLABORATIVE CONSORTIUM (EORTC 1419) von Weller, M, Felsberg, J, Gramatzki, D, Le Rhun, E, Clarke, J, Soffietti, R, Wick, W, Chinot, O, Ducray, F, Roth, P, McDonald, K, Hau, P, Hottinger, A F, Reijneveld, J, Schnell, O, Marosi, C, Glantz, M, Darlix, A, Lombardi, G, Krex, D, Glas, M, Reardon, D A, van den Bent, M J, Lefranc, F, Herrlinger, U, Razis, E, Carpentier, A F, Phillips, S, Rudà, R, Wick, A, Tabouret, E, Meyronet, D, Maurage, C, Rushing, E, Rapkins, R

Volltext

A case study of a long-term glioblastoma survivor with unmethylated MGMT and hypermutated genotype von Jue, Toni Rose, Olafson, Lauren R, Siddell, Anna H, Rapkins, Robert W, Ng, Benedict, Yin, Julia X M, Lu, Victor M, Chung, Sylvia A, Whittaker, Shane P, Davies, Matthew, Fairhall, Jacob M, Hovey, Elizabeth J, McDonald, Kerrie L

Volltext